harrison.ai, a Sydney-based breakthrough healthcare AI company, announced it has raised AU$129 million (USD$97 million) in one of Australia’s largest-ever Series B funding rounds. It brings the total raised by harrison.ai within the past two years to AU$158 million (USD$118 million).
The round was led by existing investor Horizons Ventures, featured new equity investment from Sonic Healthcare and I-MED Radiology Network, alongside existing investors Blackbird Ventures and Skip Capital.
harrison.ai also announced a new partnership with Sonic Healthcare (ASX: SHL), a leader in medical diagnostics, to co-develop and commercialize new clinical AI solutions in pathology.
The funding will go to helping harrison.ai expand on its mission to scale critical capacity in the global healthcare system through rapid commercialization of comprehensive clinical AI applications.
harrison.ai will also use the new capital to rapidly expand its team of AI data scientists and engineers while expanding into new areas of healthcare with global clinical partners.
Round: Series B
Funding Month: November 2021
Lead Investors: Horizons Ventures
Additional Investors: Sonic Healthcare, I-MED Radiology Network, Blackbird Ventures, and Skip Capital
Company Website: https://harrison.ai/
Software Category: AI-as-a-medical device solutions
About the Company: In 2018, brothers Dimitry Tran and Dr. Aengus Tran founded harrison.ai and began their journey to create accurate and clinically effective medical AI solutions. harrison.ai creates AI-as-a-medical device solutions that have a global impact and support clinical excellence. harrison.ai mission is to create AI-as-a-medical-device solutions through ventures and ultimately improve the standard of healthcare for 1million lives every day. harrison.ai currently has teams in Australia, the United Kingdom, and Vietnam, and plans to expand into other countries soon. Its products are ready for market in Australia, the U.K., Europe, and some Asian countries.